August 10, 2026 at 04:49 AM 2 min readmarketsbreaking

Molbio Diagnostics and Leap India Lead August 2026 IPO Slate

Active IPO Offerings:

Several Initial Public Offerings opened in the Indian market in August 2026, drawing strong investor interest. The Molbio Diagnostics IPO scheduled its subscription window from August 10 to August 12, 2026, with a price band of ₹768 to ₹807 per share. Meanwhile, the LEAP India IPO progressed through its active subscription phase with an issue size of ₹2,480 crores, including a fresh issue of ₹480 crores.

Schedule and Pricing:

Technocraft Ventures opened its IPO with a price band of ₹200 to ₹212, targeting an August 14 listing alongside LEAP India. Other notable public offerings included Dhoot Transmission, which set its price band at ₹829 to ₹871, and LAPL Automotive operating an SME IPO with a price range of ₹88 to ₹94. Ardee Industries concluded its mainboard subscription valued at ₹320 crore.

Market Reception:

Investor participation remains robust across mainboard and SME segments despite broader market consolidations. Grey market premiums indicate positive listing expectations for key healthcare and logistics offerings. Analysts advise investors to review fundamental valuations before bidding on upcoming issues closing later this week.
Pulse Intelligence
Context & Impact
  • Indian primary markets experienced a steady influx of mid-sized and mainboard initial public offerings throughout mid-2026.
  • Regulatory approvals paved the way for multiple diagnostic, logistics, and manufacturing firms to tap public equity.
  • Successful IPO listings in August 2026 will provide significant capital deployment opportunities for retail and institutional investors.
  • Upcoming market debuts will test secondary market liquidity and investor appetite for mid-cap segments.

Primary market liquidity is expected to see active capital absorption as multiple IPOs open simultaneously.

The Indus Pulse is committed to accuracy and transparency.
Report a CorrectionEditorial Standards